insulin aspart · NovoLog

Peptide

Approved / Phase 4Insulin receptorNo featureable registry evidence
Approvedregulatory verdict

Evidence outlook

Approved: Type 2 Diabetes, Type 1 Diabetes

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

Every registered study for this drug was reviewed, and none was selected as featured evidence for its approved use, so its Featured trials section is empty.

Also approved (1)
EU
  • Diabetes mellitus (NovoRapid, Novo Nordisk A/S)
Product first approved 1999EMA

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (66)
Type 1 Diabetes
NCT03377699 · Novo Nordisk A/S
2017-11-22 – 2020-12-17 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT03874715 · Sanofi
2019-03-11 – 2020-07-08 · Type 1 Diabetes Mellitus
What this study did
NCT04079413 · Geropharm
2019-06-03 – 2020-01-21 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT02034513 · Novo Nordisk A/S
2014-01-05 – 2016-01-11 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01513473 · Novo Nordisk A/S
2012-01-16 – 2013-07-30 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01079234 · Novo Nordisk A/S
2010-03 – 2011-05 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01074268 · Novo Nordisk A/S
2010-02 – 2010-12 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00982228 · Novo Nordisk A/S
2009-09-01 – 2010-11-08 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00474045 · Novo Nordisk A/S
2007-05 – 2010-08 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00978627 · Novo Nordisk A/S
2009-08 – 2010-05 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00623194 · Novo Nordisk A/S
2008-02 – 2009-09 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00435019 · Novo Nordisk A/S
2007-02 – 2008-09 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00447382 · Novo Nordisk A/S
2007-03 – 2008-07 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00184665 · Novo Nordisk A/S
2004-06 – 2006-09 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00095082 · Novo Nordisk A/S
2004-09 – 2005-12 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00725036 · Novo Nordisk A/S
2002-09-02 – 2004-12-14 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00595374 · Novo Nordisk A/S
2003-12-02 – 2004-10-07 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00604656 · Novo Nordisk A/S
2003-05-05 – 2004-01-29 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00312156 · Novo Nordisk A/S
2002-08 – 2003-08 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00312104 · Novo Nordisk A/S
2002-04 – 2003-03 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00832182 · Novo Nordisk A/S
1999-12-22 – 2002-11-25 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01697657 · Novo Nordisk A/S
2001-09 – 2002-11 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01486940 · Novo Nordisk A/S
2002-03 – 2002-10 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01707134 · Novo Nordisk A/S
1997-09 – 2000-05 · Diabetes, Diabetes Mellitus, Type 1
What this study did
Type 2 Diabetes
NCT05802862 · Sunshine Lake Pharma Co., Ltd.
2023-07-06 – 2024-08-16 · Diabetes
What this study did
NCT04226105 · Geropharm
2020-01-20 – 2020-12-25 · Diabetes Mellitus, Type 2, Diabetes Mellitus
What this study did
NCT02762578 · Novo Nordisk A/S
2016-05-03 – 2017-06-19 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01023165 · Global Infusion and Aspiration Systems, LLC
2009-11 – 2015-11 · Diabetes Mellitus, Metabolic Integrity
What this study did
NCT01474538 · Eli Lilly and Company
2011-12 – 2013-02 · Type 2 Diabetes Mellitus
What this study did
NCT01513590 · Novo Nordisk A/S
2012-01-16 – 2012-11-19 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01388361 · Novo Nordisk A/S
2011-09 – 2012-07 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01365507 · Novo Nordisk A/S
2011-06 – 2012-04 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01272193 · Novo Nordisk A/S
2011-01 – 2011-09 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00151697 · Rijnstate Hospital
started 2005-05 · Diabetes Mellitus Type II
What this study did
NCT01059812 · Novo Nordisk A/S
2010-02-01 – 2010-12-23 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00972283 · Novo Nordisk A/S
2009-09-01 – 2010-10-28 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01045707 · Novo Nordisk A/S
2010-01 – 2010-10 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01045447 · Novo Nordisk A/S
2010-01 – 2010-10 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01009580 · Novo Nordisk A/S
2009-11-05 – 2010-08-23 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00313001 · Novo Nordisk A/S
2006-04 – 2007-07 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00318786 · Novo Nordisk A/S
2006-04 – 2007-06 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00504673 · Novo Nordisk A/S
2005-04 – 2006-12 · Diabetes, Diabetes Mellitus, Type 2
What this study did
Phase 2/3 (6)
Type 1 Diabetes
NCT03262116 · Massachusetts General Hospital
2019-03-19 – 2019-07-23 · Type 1 Diabetes Mellitus
What this study did
NCT03565666 · Massachusetts General Hospital
2018-07-09 – 2018-11-19 · Type1 Diabetes Mellitus
What this study did
Type 2 Diabetes
NCT00228904 · Florida Atlantic University
2005-02 – 2011-10 · Diabetic Neuropathy
What this study did
Other / comorbidity
NCT02496780 · University of Minnesota
2015-08 – 2022-07 · Cystic Fibrosis
What this study did
NCT00539409 · Florida Atlantic University
2006-11 – 2009-08 · Diabetes Mellitus, With Complications
What this study did
NCT01029639 · Florida Atlantic University
2007-01 – 2009-08 · Hypoglycemia
What this study did
Phase 2 (13)
Type 1 Diabetes
NCT02509429 · University Hospital, Montpellier
2015-06-16 – 2016-12 · Type 1 Diabetes
What this study did
NCT02416765 · Institut de Recherches Cliniques de Montreal
2015-05 – 2015-10 · Type 1 Diabetes
What this study did
NCT01194245 · Halozyme Therapeutics
2010-08 – 2011-08 · Diabetes Mellitus, Type 1
What this study did
NCT00841087 · Novo Nordisk A/S
2009-01 – 2009-05 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00612040 · Novo Nordisk A/S
2008-01 – 2008-06 · Diabetes, Diabetes Mellitus, Type 1
What this study did
Type 2 Diabetes
NCT06558708 · Gan and Lee Pharmaceuticals, USA
2024-06-28 – 2024-12 · Type 2 Diabetes
What this study did
NCT01510093 · Aarhus University Hospital
2012-05 – 2013-01 · Type 2 Diabetes Mellitus
What this study did
NCT01194258 · Halozyme Therapeutics
2010-08 – 2011-08 · Diabetes Mellitus, Type II
What this study did
NCT00842361 · Novo Nordisk A/S
2009-01 – 2009-06 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00613951 · Novo Nordisk A/S
2008-01 – 2008-08 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00614055 · Novo Nordisk A/S
2008-01 – 2008-07 · Diabetes, Diabetes Mellitus, Type 2
What this study did
Other / comorbidity
NCT04292535 · Michigan State University
2018-06-15 – 2020-02-20 · Insulin, Exercise
What this study did
NCT01561378 · Albert Einstein College of Medicine
2012-08 – 2014-10 · Post-operative Cognitive Decline, Post-operative Delirium
What this study did
Phase 1/2 (2)
Other / comorbidity
NCT00581867 · Jeff Burns, MD
2007-10 – 2012-05 · Alzheimer's Disease
What this study did
NCT00353990 · University of Aarhus
2006-08 – 2006-12 · Diabetes Mellitus
What this study did
Phase 1 (56)
Type 1 Diabetes
NCT06809621 · Novo Nordisk A/S
2025-01-29 – 2025-07-28 · Diabetes Mellitus, Type 1
What this study did
NCT03666065 · Yale University
2020-01-01 – 2023-06-30 · Type1diabetes
What this study did
NCT03436498 · Sanofi
2018-05-10 – 2018-10-06 · Type 1 Diabetes Mellitus
What this study did
NCT02612844 · Novo Nordisk A/S
2015-11 – 2016-06 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT02059174 · Merck Sharp & Dohme LLC
2014-02-10 – 2015-04-27 · Type 1 Diabetes Mellitus
What this study did
NCT01773798 · Novo Nordisk A/S
2013-01 – 2013-08 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01590836 · Novo Nordisk A/S
2012-04 – 2012-06 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01455142 · Novo Nordisk A/S
2011-10 – 2012-01 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01399346 · Medical University of Graz
2011-04 – 2011-06 · Type 1 Diabetes
What this study did
NCT01269606 · Novo Nordisk A/S
2011-01 – 2011-03 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01173926 · Novo Nordisk A/S
2010-07 – 2010-11 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01174303 · Novo Nordisk A/S
2010-08 – 2010-11 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01138488 · Novo Nordisk A/S
2010-06 – 2010-11 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01051102 · Novo Nordisk A/S
2010-01 – 2010-04 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01464099 · Novo Nordisk A/S
2008-06 – 2008-11 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01868568 · Novo Nordisk A/S
2008-04 – 2008-08 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01536028 · Novo Nordisk A/S
2006-04 – 2006-07 · Diabetes, Diabetes Mellitus, Type 1
What this study did
Type 2 Diabetes
NCT07068295 · Novo Nordisk A/S
2025-07-11 – 2026-03-10 · Diabetes Mellitus, Type 2
What this study did
NCT05754424 · Arecor Limited
2023-02-27 – 2024-02-12 · Diabetes Mellitus, Type 2
What this study did
NCT01134224 · Novo Nordisk A/S
2010-05 – 2010-11 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01028404 · Novo Nordisk A/S
2009-11 – 2010-06 · Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Healthy
What this study did
NCT00184613 · Novo Nordisk A/S
2005-05 – 2006-01 · Diabetes, Diabetes Mellitus, Type 2, Delivery Systems
What this study did
NCT00115973 · Novo Nordisk A/S
2005-06 – 2006-01 · Diabetes, Diabetes Mellitus, Type 2, Delivery Systems
What this study did
Other / comorbidity
NCT05946798 · Anna Stanhewicz, PhD
2023-08-30 – 2028-06-01 · Gestational Diabetes, Oxidative Stress, Vascular Endothelial Function
What this study did
NCT06547619 · Anna Stanhewicz, PhD
2024-10-01 – 2027-05 · Gestational Diabetes, Endothelial Dysfunction, Physical Inactivity
What this study did
NCT07918898 · Gan & Lee Pharmaceuticals.
2026-11-02 – 2027-02-02 · Healthy Participants
What this study did
NCT06375031 · Jiangsu HengRui Medicine Co., Ltd.
2024-05 – 2024-07-15 · Diabetes
What this study did
NCT05737576 · Jiangsu HengRui Medicine Co., Ltd.
2023-03-20 – 2023-12-08 · Diabetes
What this study did
NCT05104424 · Ministry of Health, Saudi Arabia
2021-12-26 – 2022-10-01 · Smell Dysfunction, Taste Disorders, Taste Disorder, Secondary, Sweet, Taste Disorder, Secondary, Bitter, Smell Disorder
What this study did
NCT04660305 · Arecor Limited
2020-12-02 – 2021-06-11 · Diabetes Mellitus, Type 1
What this study did
NCT04237129 · Gan and Lee Pharmaceuticals, USA
2019-08-27 – 2019-12-16 · Diabetes Mellitus, Type 1
What this study did
NCT02462161 · Wake Forest University Health Sciences
2015-03-20 – 2019-04-16 · Alzheimer's Disease, Mild Cognitive Impairment
What this study did
NCT02844790 · Novo Nordisk A/S
2016-07-26 – 2016-09-27 · Healthy
What this study did
NCT02594033 · Novo Nordisk A/S
2015-10-27 – 2016-01-28 · Diabetes
What this study did
NCT02328040 · Albert Einstein College of Medicine
2014-09 – 2016-01 · Diabetes Mellitus, Type 1
What this study did
NCT00652288 · Yale University
2007-04 – 2011-09 · Diabetes Mellitus, Type I
What this study did
NCT01125553 · Novo Nordisk A/S
2010-05 – 2010-08 · Diabetes, Healthy
What this study did
NCT00979875 · Halozyme Therapeutics
2009-09 – 2010-05 · Healthy
What this study did
NCT00992537 · Novo Nordisk A/S
2009-10 – 2010-01 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00993096 · Novo Nordisk A/S
2009-09 – 2009-12 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01868581 · Novo Nordisk A/S
2008-05 – 2008-08 · Diabetes, Healthy
What this study did
NCT00969592 · Profil Institut für Stoffwechselforschung GmbH
2007-11 – 2008-06 · Diabetes
What this study did
NCT01530048 · Novo Nordisk A/S
2006-03 – 2006-05 · Diabetes, Healthy
What this study did
Phase 4 (72)
Type 1 Diabetes
NCT03328845 · Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
2017-01-20 – 2021-11-20 · Type 1 Diabetes Mellitus
What this study did
NCT04409587 · Mountain Diabetes and Endocrine Center
2018-04-12 – 2020-11-01 · Type1 Diabetes Mellitus
What this study did
NCT03987191 · University of Colorado, Denver
2020-01-10 – 2020-10-08 · Type 1 Diabetes
What this study did
NCT02192450 · Nordsjaellands Hospital
2015-01 – 2019-02-28 · Type 1 Diabetes Mellitus, Nocturnal Hypoglycemia, Recurrent Severe Hypoglycaemia
What this study did
NCT03260868 · Sanofi
2017-09-19 – 2018-11-22 · Type 1 Diabetes Mellitus
What this study did
NCT02685449 · Medical University of Warsaw
2016-02 – 2018-08 · Diabetes type1
What this study did
NCT02276859 · Medical University of Warsaw
2014-10 – 2015-09 · Type 1 Diabetes
What this study did
NCT01526733 · Halozyme Therapeutics
2011-12 – 2013-09 · Type 1 Diabetes Mellitus
What this study did
NCT01678235 · Medical University of Warsaw
2011-09 – 2012-09 · Type 1 Diabetes Mellitus
What this study did
NCT00346996 · Lise Tarnow
2007-05 – 2012-08 · Type 1 Diabetes
What this study did
NCT00913497 · Corewell Health West
2009-06 – 2012-01 · Type 1 Diabetes Mellitus
What this study did
NCT00505882 · University of Texas Southwestern Medical Center
2007-07 – 2008-12 · Type 1 Diabetes
What this study did
NCT00461331 · Tulane University Health Sciences Center
2004-10 – 2008-08 · Type 1 Diabetes Mellitus
What this study did
NCT00509925 · Novo Nordisk A/S
2007-07 – 2008-07 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00497536 · University of Aarhus
2007-07 – 2008-07 · Type 1 Diabetes Mellitus
What this study did
NCT00117780 · Novo Nordisk A/S
2005-06 – 2006-10 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00145353 · Odense University Hospital
2004-11 – 2006-06 · Type 1 Diabetes Mellitus
What this study did
NCT00365170 · Novo Nordisk A/S
2002-09 – 2005-04 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00571935 · Novo Nordisk A/S
2003-08 – 2004-10 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01467141 · Novo Nordisk A/S
2002-06-19 – 2003-10-15 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00597233 · Novo Nordisk A/S
2002-10 – 2002-12 · Diabetes, Diabetes Mellitus, Type 1
What this study did
Type 2 Diabetes
NCT06127433 · Sun Yat-sen University
2023-03-07 – 2024-12-30 · Insulin Pump,Continuous Glucose Monitoring Technology
What this study did
NCT04538352 · The Cleveland Clinic
2021-01-18 – 2023-11-01 · Type 2 Diabetes
What this study did
NCT03336528 · Emory University
2018-01-02 – 2021-03-01 · Type 2 Diabetes
What this study did
NCT02408120 · Emory University
2015-10 – 2019-12-11 · Diabetes Mellitus, Type 2
What this study did
NCT01966978 · University of Texas Southwestern Medical Center
2014-11 – 2017-12 · Diabetes Mellitus, Type 2, Diabetes
What this study did
NCT02453685 · Novo Nordisk A/S
2015-08-31 – 2016-09-20 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT03226210 · Nanjing First Hospital, Nanjing Medical University
2015-02-01 – 2016-07-01 · Diabetes Mellitus, Type 2
What this study did
NCT00821795 · Dennis G. Karounos, M.D.
2009-03-11 – 2013-04-23 · Type 2 Diabetes Mellitus
What this study did
NCT00942318 · University Hospital, Toulouse
2009-03 – 2013-02 · Type 2 Diabetes Mellitus
What this study did
NCT01407289 · Medical University of Graz
2011-06 – 2012-04 · Diabetes Mellitus, Type 2
What this study did
NCT01165684 · Novo Nordisk A/S
2010-10 – 2012-04 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00771693 · Karolinska Institutet
2007-05 – 2011-07 · Type 2 Diabetes Mellitus, Postprandial Hyperglycemia
What this study did
NCT00906529 · University of Texas Southwestern Medical Center
2009-05 – 2011-03 · Type 2 Diabetes
What this study did
NCT01293396 · Medical University of Graz
2010-06 – 2011-03 · Type 2 Diabetes
What this study did
NCT00998335 · University of Florida
2007-06 – 2010-02 · Type 2 Diabetes
What this study did
NCT00591227 · Rush University Medical Center
2008-05 – 2009-07 · Type 2 Diabetes Mellitus
What this study did
NCT00747409 · Munich Municipal Hospital
2004-07 – 2009-06 · Type 2 Diabetes Mellitus
What this study did
NCT00537303 · Novo Nordisk A/S
2007-10 – 2009-03 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00590226 · Emory University
2006-12 – 2008-04 · Type 2 Diabetes
What this study did
NCT00121966 · Odense University Hospital
2003-01 – 2007-07 · Type 2 Diabetes Mellitus
What this study did
NCT00274274 · Novo Nordisk A/S
2005-09 – 2006-11 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00282451 · Novo Nordisk A/S
2006-02 – 2006-08 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00101751 · Novo Nordisk A/S
2004-10 – 2006-06 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00494988 · Novo Nordisk A/S
2004-12 – 2006-04 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00254085 · University Hospital, Gentofte, Copenhagen
2005-03 – 2006-03 · Type 2 Diabetes
What this study did
Early phase / not applicable (26)
Type 1 Diabetes
NCT06532461 · Steno Diabetes Center Copenhagen
2024-07-20 – 2026-12-31 · Type 1 Diabetes
What this study did
NCT04200313 · Jaeb Center for Health Research
2020-03-31 – 2022-01-14 · Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT04031599 · Institut de Recherches Cliniques de Montreal
2020-07-10 – 2021-12-14 · Type 1 Diabetes
What this study did
NCT04055480 · University of Cambridge
2019-08-10 – 2020-08-30 · Type 1 Diabetes
What this study did
NCT04112069 · Massachusetts General Hospital
2018-07-09 – 2018-11-19 · Type1 Diabetes Mellitus
What this study did
NCT02824510 · Cliniques universitaires Saint-Luc- Université Catholique de Louvain
2014-08 – 2017-01 · Type 1 Diabetes
What this study did
NCT01621776 · University of Florida
2011-06 – 2012-08 · Type 1 Diabetes
What this study did
NCT01223560 · Hvidovre University Hospital
2009-10 – 2010-05 · Type 1 Diabetes
What this study did
NCT00428207 · Joslin Diabetes Center
2007-02 – 2008-08 · Type 1 Diabetes Mellitus
What this study did
NCT00283218 · University of Aarhus
2006-01 – 2006-08 · Type 1 Diabetes
What this study did
Type 2 Diabetes
NCT07652528 · Hallym University
2026-08 – 2028-12 · Sudden Sensorineural Hearing Loss (SSNHL), Prediabetes / Type 2 Diabetes
What this study did
NCT05417841 · Beijing Hospital
2023-03-23 – 2025-08-15 · Type 2 Diabetes Mellitus
What this study did
NCT01588743 · Li Guangwei
2008-10 – 2012-12 · Type 2 Diabetes Mellitus
What this study did
Other / comorbidity
NCT07875803 · Zhuhai United Laboratories Co., Ltd.
2026-10-20 – 2027-02-28 · Pharmacokinetics and Pharmacodynamics
What this study did
NCT07600944 · Zhuhai United Laboratories Co., Ltd.
2026-05-06 – 2026-07-03 · Pharmacokinetics and Pharmacodynamics
What this study did
NCT04184466 · Geropharm
2018-10-18 – 2018-12-19 · Clamp Study
What this study did
NCT01149005 · Hadassah Medical Organization
2010-06 – 2015-12 · Cystic Fibrosis, Impaired Glucose Tolerance, Pulmonary Exacerbation
What this study did
NCT01947556 · University Medical Center Nijmegen
2014-03 – 2014-11 · Diabetes Mellitus
What this study did
NCT02144441 · University of Pennsylvania
2014-06 – 2014-10 · Diabetes Mellitus
What this study did
NCT01933490 · University of Minnesota
2013-08 – 2014-08 · Hyperinsulinemic Hypoglycemia
What this study did
NCT00625781 · Region Örebro County
2008-02 – 2013-12 · Impaired Glucose Tolerance, Fetal Macrosomia
What this study did
NCT01702311 · Emory University
2012-05 – 2013-12 · Diabetes
What this study did
NCT00353431 · University Hospital, Basel, Switzerland
2006-12 – 2010-10 · Hyperglycemias
What this study did
NCT00920725 · Rush University Medical Center
2005-01 – 2007-12 · Diabetic Ketoacidosis
What this study did
NCT00410033 · Novo Nordisk A/S
1989-12 – 2006-05 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00206206 · Atlantic Health System
started 2005-07 · Hyperglycemia
What this study did
Used as active comparator (48)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (19)
Type 1 Diabetes
NCT01445951 · Mannkind Corporation
2011-09 – 2013-06 · Type 1 Diabetes Mellitus
What this study did
NCT00322257 · Novo Nordisk A/S
2006-05-01 – 2008-04-02 · Diabetes, Diabetes Mellitus, Type 1
What this study did
Type 2 Diabetes
NCT05767255 · Hospital Universitario San Ignacio
2022-12-01 – 2023-08-30 · Diabetes Mellitus, Type 2 Treated With Insulin
What this study did
NCT03689374 · Novo Nordisk A/S
2018-10-01 – 2021-02-22 · Diabetes Mellitus, Type 2
What this study did
NCT03211858 · Sanofi
2017-08-02 – 2019-01-12 · Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus
What this study did
NCT02420262 · Novo Nordisk A/S
2015-07-26 – 2016-10-05 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01196104 · Mannkind Corporation
2010-09 – 2012-03 · Type 2 Diabetes
What this study did
NCT00184600 · Novo Nordisk A/S
2004-11 – 2009-08 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00434954 · AstraZeneca
2007-02 – 2009-06 · Type 2 Diabetes Mellitus
What this study did
NCT00082407 · AstraZeneca
2003-11 – 2008-07 · Diabetes Mellitus, Type 2
What this study did
NCT00331604 · Novo Nordisk A/S
2006-08-31 – 2008-05-05 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00472953 · Novo Nordisk A/S
2007-05-15 – 2008-03-05 · Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Chronic Obstructive Pulmonary Disease
What this study did
NCT00523042 · Novo Nordisk A/S
2007-08-30 – 2008-02-28 · Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Asthma
What this study did
Other / comorbidity
NCT03737240 · Emory University
2019-01-15 – 2022-07-08 · Diabetes Mellitus
What this study did
NCT01134107 · Eli Lilly and Company
2010-11 – 2011-12 · Diabetes Mellitus, Type 1
What this study did
NCT01109316 · Eli Lilly and Company
2010-04 – 2011-08 · Diabetes Mellitus, Type 1
What this study did
Phase 2/3 (3)
Type 2 Diabetes
NCT03430856 · Biocon Limited
2017-12-26 – 2019-02-20 · Type2 Diabetes Mellitus
What this study did
Other / comorbidity
Phase 2 (4)
Type 1 Diabetes
NCT00850161 · CPEX Pharmaceuticals Inc.
2009-07 – 2010-09 · Type 1 Diabetes Mellitus
What this study did
Type 2 Diabetes
NCT07387003 · Gan & Lee Pharmaceuticals.
2026-04-10 – 2027-09-23 · Type 2 Diabetes (T2DM)
What this study did
NCT06199505 · Gan and Lee Pharmaceuticals, USA
2023-11-21 – 2024-07-12 · Type 2 Diabetes
What this study did
Other / comorbidity
NCT00624767 · Nastech Pharmaceutical Company, Inc.
2008-03 – 2008-05 · Diabetes Mellitus
What this study did
Phase 1/2 (1)
Type 1 Diabetes
NCT03981627 · Adocia
2019-06-06 – 2020-06-27 · Type 1 Diabetes Mellitus
What this study did
Phase 1 (6)
Type 1 Diabetes
NCT03449433 · Eli Lilly and Company
2018-03-15 – 2018-08-14 · Diabetes Mellitus, Type 1
What this study did
NCT02938572 · Novo Nordisk A/S
2016-10-19 – 2017-07-04 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT03202875 · Sanofi
2012-11-14 – 2012-12-28 · Type 1 Diabetes
What this study did
Other / comorbidity
NCT06492226 · Xentria, Inc.
2024-07-30 – 2024-10-31 · Healthy Participants
What this study did
NCT05719961 · Jiangsu HengRui Medicine Co., Ltd.
2023-01-05 – 2023-07-30 · Diabetes
What this study did
Phase 4 (10)
Type 2 Diabetes
NCT03660553 · University of Miami
2018-10-10 – 2022-06-30 · Type 2 Diabetes Mellitus
What this study did
NCT04120623 · Nanjing First Hospital, Nanjing Medical University
2019-10-01 – 2020-02-28 · Type 2 Diabetes Mellitus
What this study did
NCT02467920 · Huazhong University of Science and Technology
2015-08 – 2017-12 · Type 2 Diabetes Mellitus
What this study did
NCT00965549 · Sanofi
2009-07 – 2012-12 · Diabetes Mellitus, Type 2
What this study did
NCT00657943 · Steno Diabetes Center Copenhagen
2008-04 – 2012-12 · Type 2 Diabetes, Atherosclerosis, Arteriosclerosis
What this study did
NCT01079364 · Sanofi
2010-01 – 2012-07 · Diabetes Mellitus, Type 2
What this study did
NCT01417897 · ikfe-CRO GmbH
2011-09 – 2012-05 · Type 2 Diabetes Mellitus
What this study did
NCT00467649 · AstraZeneca
2007-05 – 2008-04 · Type 2 Diabetes Mellitus
What this study did
Other / comorbidity
NCT04012138 · Nantes University Hospital
2019-12-20 – 2025-12-20 · Hyperkalemia
What this study did
Early phase / not applicable (5)
Type 1 Diabetes
NCT06948760 · Mark D. DeBoer, MD, MSc., MCR
2025-07-23 – 2026-03-10 · Type 1 Diabetes
What this study did
NCT04965051 · Second Affiliated Hospital, Zhejiang University, School of Medicine
2021-08 – 2023-12 · Type 1 Diabetes Mellitus With Diabetic Gastroparesis, HbA1c, Time in Range
What this study did
Type 2 Diabetes
NCT03987308 · Beijing Hospital
2019-07-02 – 2025-12 · Type 2 Diabetic Patients, T2DM (Type 2 Diabetes Mellitus), T2DM
What this study did
NCT02887625 · Dr. Muhammad Abdulghani
2015-02 – 2017-05 · Type 2 Diabetes
What this study did
Other / comorbidity
NCT00574405 · Arkansas Children's Hospital Research Institute
2005-04 – 2011-03 · Diabetes Mellitus
What this study did
Studied as part of a combination product (3)

Studies of a fixed-dose combination that contains this drug. The combination is the product under test, so these are that product's evidence rather than this one's; the link is kept because the drug really was administered.

Phase 3 (2)
Type 2 Diabetes
NCT01520753 · Novo Nordisk A/S
1999-03 – 1999-06 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01467323 · Novo Nordisk A/S
1998-04 – 1998-09 · Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
What this study did
Phase 4 (1)
Type 2 Diabetes
NCT07173712 · Yanbing Li
2026-03-15 – 2027-12-31 · Type 2 Diabetes
What this study did
Appears in other studies (8)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 3 (1)
Type 1 Diabetes
Phase 1 (1)
Other / comorbidity
NCT05946785 · Anna Stanhewicz, PhD
2023-07-01 – 2027-06-01 · Gestational Diabetes, Vascular Endothelial Function
What this study did
Phase 4 (3)
Type 2 Diabetes
NCT02556918 · Emory University
2016-01 – 2018-11-06 · Hyperglycemia
What this study did
Other / comorbidity
NCT02741687 · Emory University
2016-06 – 2017-04 · Hyperglycemia
What this study did
NCT02443402 · Emory University
2016-01 – 2016-12 · Coronary Artery Disease
What this study did
Early phase / not applicable (3)
Type 1 Diabetes
NCT05221359 · Defymed
2022-05-05 – 2027-04 · Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia
What this study did
NCT01531855 · Northumbria University
2012-02 – 2012-08 · Type 1 Diabetes
What this study did
Other / comorbidity
NCT00464854 · Assaf-Harofeh Medical Center
2005-07 – 2006-09 · Diabetes Mellitus
What this study did

Competitive landscape

This mechanism is crowded: 8 other tracked programmes target it, none of them ahead of this one.

This drug's own stage for Type 1 Diabetes: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Insulin Aspart (NovoLog): this drugApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
AfrezzaApprovedPeptideInsulinPartial signal
NCT04974528: HbA1c change at week 26 (ITT, n=117 vs 113): Afrezza +0.19 vs rapid-acting insulin analog +0.01; difference 0.18 percentage points (95% CI -0.07 to 0.44); non-inferiority (0.4% margin) not met, one-sided adjusted p=0.058. missed
NCT01445951: Change in HbA1c from baseline to week 24 (LS mean): Technosphere Insulin (Gen2 inhaler) plus basal insulin -0.21% vs insulin aspart plus basal insulin -0.40%; difference 0.19% (95% CI 0.02 to 0.36), inside the pre-specified non-inferiority margin of 0.4% (CT.gov posted analysis).
Insulin Aspart (Fiasp)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin Degludec (Tresiba)ApprovedPeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Detemir (Levemir)
ApprovedUS marketing discontinued
PeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Glargine (Lantus)ApprovedPeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Glargine (Basaglar)ApprovedPeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Glargine (Toujeo)ApprovedPeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Glulisine (Apidra)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin HumanApproved—Insulinnot yet gradedNo reviewed efficacy summary in this indication
Insulin Lispro (Humalog)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin Lispro (Lyumjev)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin NPH (Humulin N)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Pramlintide (Symlin)
ApprovedUS marketing discontinued
PeptideAmylin receptornot yet gradedNo reviewed efficacy summary in this indication
CadisegliatinPhase 3Small moleculeGlucokinasenot yet gradedNo reviewed efficacy summary in this indication
Sotagliflozin (Inpefa)Phase 3Small moleculeSGLT1/2 (dual)not yet gradedNo reviewed efficacy summary in this indication
ZimislecelPhase 3Cell therapyPancreatic islet cells (VX-880 is a stem cell-derived therapy, not a small molecule drug), Pancreatic islet cell replacementnot yet gradedNo reviewed efficacy summary in this indication
IcovamenibPhase 2Small moleculeMeninnot yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(4 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow NovoLog (insulin aspart) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (1)
December 2026 (1)
Early phase / not applicableType 1 DiabetesRecruiting
Est. primary completion 2026-12-31 · NCT06532461 · CT.gov ↗
What to watch
2027 (2)
February 2027 (2)
Phase 1Healthy ParticipantsRecruiting
Est. primary completion 2027-02-02 · NCT07918898 · CT.gov ↗
What to watch
Early phase / not applicablePharmacokinetics and PharmacodynamicsNot yet recruiting
Est. primary completion 2027-02-28 · NCT07875803 · CT.gov ↗
What to watch
2028 (1)
June 2028 (1)
Early phase / not applicableType 2 DiabetesNot yet recruiting
Est. primary completion 2028-06 · NCT07652528 · CT.gov ↗
What to watch

See the full readout calendar ↗